Complexities in the development of cyclin-dependent kinase inhibitor drugs

This publication has 51 references indexed in Scilit:

• The G2-phase DNA-damage checkpoint
  Trends in Cell Biology, 2000
• Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription
  Molecular and Cellular Biology, 2000
• Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators
  JNCI Journal of the National Cancer Institute, 2000
• CDK inhibitors: positive and negative regulators of G1-phase progression
  Genes & Development, 1999
• Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
  Proceedings of the National Academy of Sciences, 1999
• The regulation of E2F by pRB-family proteins
  Genes & Development, 1998
• Temporal Regulation of RNA Polymerase II by Srb10 and Kin28 Cyclin-Dependent Kinases
  Molecular Cell, 1998
• Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages
  The EMBO Journal, 1998
• Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
  Genes & Development, 1997
• Principles of CDK regulation
  Nature, 1995